Ligand Pharmaceuticals Inc Sustainability Reports
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring royalty-generating assets coupled with an efficient corporate cost structure. The company licenses its technologies, such as Captisol, to assist biopharmaceutical companies globally in financing and advancing clinical development programs.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 5493008K7TB0IKP37H79
FIGI: BBG001S8CH99
15 reports from 2008 to 2025
